CHIMERIC ANTIGEN RECEPTOR; ACUTE LYMPHOBLASTIC-LEUKEMIA; ADOPTIVE IMMUNOTHERAPY; CANCER-IMMUNOTHERAPY; MONOCLONAL-ANTIBODY; ADVERSE EVENT; SAFETY SWITCH; IN-VITRO; THERAPY; DESIGN
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, v.113, no.4, pp.459 - 468
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.